Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,500 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 5 August 2020) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

 (PDF, 3MB, 207 pages) 

This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website. 

 

 

Export 2566 results:
Author Title Type [ Year(Asc)]
2019
L. Harris, Graham, S., MacLachlan, S., Exuzides, A., and Jacob, S., “Healthcare resource utilization by patients with treatment-refractory myasthenia gravis in England”, J Med Econ, pp. 1-7, 2019.
G. Ferreira, Stuurman, A. L., Horsmans, Y., Cattaert, T., Verstraeten, T., Feng, Y., Rosillon, D., and Guignard, A., “Hepatitis B virus infection and the risk of liver disease progression in type 2 diabetic patients with potential nonalcoholic fatty liver disease: a retrospective, observational, cohort study in the United Kingdom Clinical Practice Research Datalink”, Eur J Gastroenterol Hepatol, 2019.
D. Curran, Hunjan, M., A. Ghachi, E., El-Hahi, Y., Bianco, V., and Ferreira, G., “Herpes zoster related healthcare burden and costs in immunocompromised (IC) and IC-free populations in England: an observational retrospective database analysis”, BMJ Open, vol. 9, p. e023502, 2019.
K. Richardson, Mattishent, K., Loke, Y. K., Steel, N., Fox, C., Grossi, C. M., Bennett, K., Maidment, I., Boustani, M., Matthews, F. E., Myint, P. K., Campbell, N. L., Brayne, C., Robinson, L., and Savva, G. M., “History of Benzodiazepine Prescriptions and Risk of Dementia: Possible Bias Due to Prevalent Users and Covariate Measurement Timing in a Nested Case-Control Study”, Am J Epidemiol, vol. 188, pp. 1228-1236, 2019.
R. E. Ghosh, Crellin, E., Beatty, S., Donegan, K., Myles, P., and Williams, R., “How Clinical Practice Research Datalink data are used to support pharmacovigilance”, Therapeutic Advances in Drug Safety, 2019.
H. Carreira, Williams, R., Strongman, H., and Bhaskaran, K., “Identification of mental health and quality of life outcomes in primary care databases in the UK: a systematic review”, BMJ Open, vol. 9, p. e029227, 2019.
B. Carter, C. Bennett, V., Bethel, J., Jones, H. M., Wang, T., and Kemp, A., “Identifying cerebral palsy from routinely-collected data in England and Wales”, Clin Epidemiol, vol. 11, pp. 457-468, 2019.
M. Pikoula, Quint, J. K., Nissen, F., Hemingway, H., Smeeth, L., and Denaxas, S., “Identifying clinically important COPD sub-types using data-driven approaches in primary care population based electronic health records”, BMC Med Inform Decis Mak, vol. 19, p. 86, 2019.
B. M. Shields, Hattersley, A. T., and Farmer, A. J., “Identifying routine clinical predictors of non-adherence to second line therapies in Type 2 diabetes: a retrospective cohort analysis in a large primary care database”, Diabetes Obes Metab, 2019.
E. Ford, Rooney, P., Oliver, S., Hoile, R., Hurley, P., Banerjee, S., van Marwijk, H., and Cassell, J., “Identifying undetected dementia in UK primary care patients: a retrospective case-control study comparing machine-learning and standard epidemiological approaches”, BMC Med Inform Decis Mak, vol. 19, p. 248, 2019.
P. Tammes, Payne, R. A., Salisbury, C., Chalder, M., Purdy, S., and Morris, R. W., “The impact of a named GP scheme on continuity of care and emergency hospital admission: a cohort study among older patients in England, 2012-2016”, BMJ Open, vol. 9, p. e029103, 2019.
V. Allan, Sammon, C. J., McDonald, L., Mehmud, F., Alikhan, R., and Ramagopalan, S. V., “Impact of atrial fibrillation awareness campaigns: interrupted time series using the Clinical Practice Research Datalink”, Future Cardiol, 2019.
N. Al-Attar, Johnston, S., Jamous, N., Mistry, S., Ghosh, E., Gangoli, G., Danker, W., Etter, K., and Ammann, E., “Impact of bleeding complications on length of stay and critical care utilization in cardiac surgery patients in England”, J Cardiothorac Surg, vol. 14, p. 64, 2019.
E. Burn, Edwards, C. J., Murray, D. W., Silman, A., Cooper, C., Arden, N. K., Prieto-Alhambra, D., and Pinedo-Villanueva, R., “The impact of bmi and smoking on risk of revision following knee and hip replacement surgery: evidence from routinely collected data”, Osteoarthritis Cartilage, 2019.
D. Z. I. Cherney, Repetto, E., Wheeler, D. C., Arnold, S. V., MacLachlan, S., Hunt, P. R., Chen, H., Vora, J., and Kosiborod, M., “Impact of Cardio-Renal-Metabolic Comorbidities on Cardiovascular Outcomes and Mortality in Type 2 Diabetes Mellitus”, Am J Nephrol, pp. 1-9, 2019.
J. Ride, Kasteridis, P., Gutacker, N., Doran, T., Rice, N., Gravelle, H., Kendrick, T., Mason, A., Goddard, M., Siddiqi, N., Gilbody, S., Williams, R., Aylott, L., Dare, C., and Jacobs, R., “Impact of family practice continuity of care on unplanned hospital use for people with serious mental illness”, Health Serv Res, 2019.
L. Han, Clegg, A., Doran, T., and Fraser, L., “The impact of frailty on healthcare resource use: a longitudinal analysis using the Clinical Practice Research Datalink in England”, Age Ageing, 2019.
C. D. Steer, Macleod, J., Tilling, K., Lim, A. G., Marsden, J., Millar, T., Strang, J., Telfer, M., Whitaker, H., Vickerman, P., and Hickman, M., “The impact of opiate substitution treatment on mortality risk in drug addicts: a natural experiment study”, Health Services and Delivery Research, vol. 7, no. 3, 2019.
J. Blackwell, Saxena, S., Alexakis, C., Bottle, A., Cecil, E., Majeed, A., and Pollok, R. C., “The impact of smoking and smoking cessation on disease outcomes in ulcerative colitis: a nationwide population-based study”, Aliment Pharmacol Ther, vol. 50, pp. 556-567, 2019.
J. T. H. Nielen, Dagnelie, P. C., Boonen, A., Klungel, O., van den Bemt, B., and de Vries, F., “Impact of the definition of osteoarthritis and of the timing of its onset on the association between type 2 diabetes mellitus and osteoarthritis: Clinical Practice Research Datalink”, Diabetes Res Clin Pract, vol. 148, pp. 240-248, 2019.
H. C. Patel, Hayward, C., Patel, K. S., Claggett, B., Vazir, A., and Cowie, M. R., “Impact on survival of combination inhalers in patients with COPD at high risk of cardiovascular events”, Int J Cardiol, 2019.
R. Gafoor, Charlton, J., Ravindrarajah, R., and Gulliford, M. C., “Importance of Frailty for Association of Antipsychotic Drug Use with Risk of Fracture: Cohort Study Using Electronic Health Records”, J Am Med Dir Assoc, 2019.
C. I. Bloom, Walker, S., and Quint, J. K., “Inadequate specialist care referrals for high-risk asthma patients in the UK: an adult population-based cohort 2006-2017”, J Asthma, pp. 1-7, 2019.
L. Ibanez, Sabate, M., Vidal, X., Ballarin, E., Rottenkolber, M., Schmiedl, S., Heeke, A., Huerta, C., E. Merino, M., Montero, D., Leon-Munoz, L. M., Gasse, C., Moore, N., Droz, C., Lassalle, R., Aakjaer, M., Andersen, M., De Bruin, M. L., Groenwold, R., van den Ham, R., Souverein, P., Klungel, O., and Gardarsdottir, H., “Incidence of Direct Oral Anticoagulant use in patients with non-valvular atrial fibrillation and characteristics of users in six European countries (2008-2015): A cross-national drug utilization study”, Br J Clin Pharmacol, 2019.
V. Cairns, Wallenhorst, C., Rietbrock, S., and Martinez, C., “Incidence of Lyme disease in the UK: a population-based cohort study”, BMJ Open, vol. 9, p. e025916, 2019.
K. Davies, Johnson, E. L., Hollen, L., Jones, H. M., Lyttle, M. D., Maguire, S., and Kemp, A. M., “Incidence of medically attended paediatric burns across the UK”, Inj Prev, 2019.
N. E. O'Connell, Smith, K. J., Peterson, M. D., Ryan, N., Liverani, S., Anokye, N., Victor, C., and Ryan, J. M., “Incidence of osteoarthritis, osteoporosis and inflammatory musculoskeletal diseases in adults with cerebral palsy: A population-based cohort study”, Bone, vol. 125, pp. 30-35, 2019.
L. Wei, Lai, E. C., Kao-Yang, Y. H., Walker, B. R., MacDonald, T. M., and Andrew, R., “Incidence of type 2 diabetes mellitus in men receiving steroid 5alpha-reductase inhibitors: population based cohort study”, Bmj, vol. 365, p. l1204, 2019.
A. Gayle, Dickinson, S., Poole, C., Pang, M., Fauconnot, O., and Quint, J. K., “Incidence of type II diabetes in chronic obstructive pulmonary disease: a nested case-control study”, NPJ Prim Care Respir Med, vol. 29, p. 28, 2019.
T. S. Field, Weijs, B., Curcio, A., Giustozzi, M., Sudikas, S., Katholing, A., Wallenhorst, C., Weitz, J. I., Cohen, A. T., and Martinez, C., “Incident Atrial Fibrillation, Dementia and the Role of Anticoagulation: A Population-Based Cohort Study”, Thromb Haemost, 2019.
H. R. Whittaker, Mullerova, H., Jarvis, D., Barnes, N. C., Jones, P. W., Compton, C. H., Kiddle, S. J., and Quint, J. K., “Inhaled corticosteroids, blood eosinophils, and FEV1 decline in patients with COPD in a large UK primary health care setting”, Int J Chron Obstruct Pulmon Dis, vol. 14, pp. 1063-1073, 2019.
G. Muduma, Aluvihare, V., Clancy, M., de Nigris, E., Whitlock, C., Landeira, M., and Nazir, J., “The Last Year Before Graft Failure Negatively Impacts Economic Outcomes and is Associated With Greater Healthcare Resource Utilization Compared With Previous Years in the United Kingdom: Results of a Retrospective Observational Study”, Transplant Direct, vol. 5, p. e443, 2019.
H. Strongman, Williams, R., Meeraus, W., Murray-Thomas, T., Campbell, J., Carty, L., Dedman, D., Gallagher, A., Oyinlola, J., Kousoulis, A., and Valentine, J., “Limitations for health research with restricted data collection from UK primary care”, Pharmacoepidemiol Drug Saf, 2019.
J. E. Kimpton, Carey, I. M., Threapleton, C. J. D., Robinson, A., Harris, T., Cook, D. G., DeWilde, S., and Baker, E. H., “Longitudinal exposure of English primary care patients to pharmacogenomic drugs: an analysis to inform design of pre-emptive pharmacogenomic testing”, Br J Clin Pharmacol, 2019.
T. Itani, Rai, D., Jones, T., Taylor, G. M. J., Thomas, K. H., Martin, R. M., Munafo, M. R., Davies, N. M., and Taylor, A. E., “Long-term effectiveness and safety of varenicline and nicotine replacement therapy in people with neurodevelopmental disorders: A prospective cohort study”, Sci Rep, vol. 9, p. 19488, 2019.
M. Sabido, Thilo, H., and Guido, G., “Long-term effectiveness of bisoprolol in patients with angina: A real-world evidence study”, Pharmacol Res, vol. 139, pp. 106-112, 2019.
O. Moussa, Ardissino, M., Tang, A., Lazzari, L., Millar, O., Ziprin, P., Darzi, A., Khan, O., Collins, P., and Purkayastha, S., “Long-term Impact of Bariatric Surgery on Venous Thromboembolic Risk: A Matched Cohort Study”, Ann Surg, 2019.
D. Sumilo, Nirantharakumar, K., Willis, B. H., Rudge, G., Martin, J., Gokhale, K., Thayakaran, R., Adderley, N. J., Chandan, J. S., Okoth, K., Hewston, R., Skrybant, M., Deeks, J. J., and Brocklehurst, P., “Long-term impact of giving antibiotics before skin incision versus after cord clamping on children born by caesarean section: protocol for a longitudinal study based on UK electronic health records”, BMJ Open, vol. 9, p. e033013, 2019.
J. A. Rassen, Bartels, D. B., Schneeweiss, S., Patrick, A. R., and Murk, W., “Measuring prevalence and incidence of chronic conditions in claims and electronic health record databases”, Clin Epidemiol, vol. 11, pp. 1-15, 2019.
N. J. Ailabouni, Marcum, Z. A., Schmader, K. E., and Gray, S. L., “Medication Use Quality and Safety in Older Adults: 2018 Update”, J Am Geriatr Soc, 2019.
H. Strongman, Gadd, S., Matthews, A., Mansfield, K. E., Stanway, S., Lyon, A. R., dos-Santos-Silva, I., Smeeth, L., and Bhaskaran, K., “Medium and long-term risks of specific cardiovascular diseases in survivors of 20 adult cancers: a population-based cohort study using multiple linked UK electronic health records databases”, Lancet, 2019.
R. E. Farmer, Ford, D., Mathur, R., Chaturvedi, N., Kaplan, R., Smeeth, L., and Bhaskaran, K., “Metformin use and risk of cancer in patients with type 2 diabetes: a cohort study of primary care records using inverse probability weighting of marginal structural models”, Int J Epidemiol, 2019.
C. Minassian, Williams, R., Meeraus, W. H., Smeeth, L., Campbell, O. M. R., and Thomas, S. L., “Methods to generate and validate a Pregnancy Register in the UK Clinical Practice Research Datalink primary care database”, Pharmacoepidemiol Drug Saf, vol. 28, pp. 923-933, 2019.
R. Brauer, Herrero-Zazo, M., Barlow, D. J., Gaughran, F., Taylor, D., and Howard, L. M., “Minocycline and the risk of acute psychiatric events in adolescence: A self-controlled case series”, J Psychopharmacol, p. 269881118821852, 2019.
E. R. Berni, Jones, B. I., Berni, T. R., Whitehouse, J., Hudson, M., Orr, J., Conway, P., Amlani, B., and Currie, C. J., “The Model of Mortality with Incident Cirrhosis (MoMIC) and the model of Long-term Outlook of Mortality in Cirrhosis (LOMiC)”, PLoS One, vol. 14, p. e0223253, 2019.
A. Green, Shaddick, G., Charlton, R., Snowball, J., Nightingale, A., Smith, C., Tillett, W., and McHugh, N., “Modifiable risk factors and the development of psoriatic arthritis in people with psoriasis”, Br J Dermatol, 2019.
J. M. Ryan, Peterson, M. D., Ryan, N., Smith, K. J., N, E. O. 'Connell, Liverani, S., Anokye, N., Victor, C., and Allen, E., “Mortality due to cardiovascular disease, respiratory disease, and cancer in adults with cerebral palsy”, Dev Med Child Neurol, 2019.
E. Gieling, de Vries, F., Williams, R., van Onzenoort, H. A. W., de Boer, A., V. Cate, T., Kramers, C., and Burden, A., “Mortality risk in atrial fibrillation: the role of aspirin, vitamin K and non-vitamin K antagonists”, Int J Clin Pharm, 2019.
R. Persson, Lee, S., Yood, M. U., Wagner, M., Minton, N., Niemcryk, S., Lindholm, A., Evans, A., and Jick, S., “Multi-database study of multiple sclerosis: identification, validation and description of MS patients in two countries”, J Neurol, 2019.
M. H. Secrest, Platt, R. W., Reynier, P., Dormuth, C. R., Benedetti, A., and Filion, K. B., “Multiple imputation for systematically missing confounders within a distributed data drug safety network: A simulation study and real-world example”, Pharmacoepidemiol Drug Saf, 2019.
[Page last reviewed 5 August 2020]